Introduction
, Roohi Rasool 1 * cells (Matullo et al., 2001b; Nassiri et al., 2013) . DSBR pathway is responsible for repairing double-strand breaks resulting from exogenous as well as endogenous agents such as ionizing radiation or environmental carcinogens and endogenously generated ROS. They can also be produced when DNA replication encounter DNA singlestrand breaks or other types of lesion (Jacobsen et al., 2004) . XRCC3, which participates in DNA double-strand break via homologous recombinational repair, is a member of an emerging family of Rad-51-related proteins that likely participate in homologous recombinational repair (HRR) in order to maintain chromosome stability (Tebbs et al., 1995) . XRCC3 along with Rad51 and Xrcc2 form the core component of DNA double strand breaks (DSBs) repair by HRR (Nissar et al., 2014) .
A common polymorphism in exon 7 of the XRCC3 gene results in an amino acid substitution at codon 241 (Thr241Met) due to C18067T transition affecting the enzyme function and/or its interaction with other proteins involved in DNA damage and repair (Matullo et al., 2001b) . Several studies have been conducted on XRCC3 gene polymorphism in cancer. Many of them have proved the association between this polymorphism and an increased risk, like in lung (Jacobsen et al., 2004; Ryk et al., 2006) , skin (Winsey et al., 2000; Blankenburg et al., 
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2005), breast (Smith et al., 2003) and colorectal (Mort et al., 2003 , Zhoa et al., 2012 cancer.
In the present work we analysed the potential influence of Thr241Met polymorphism of the XRCC3 gene on the CRC risk and clinico-pathological parameters in a Kashmiri population.
Materials and Methods

Subjects
This study included 120 consecutive primary colorectal cancer patients. All CRC patients were recruited from Department of Surgery, Sher-I-Kashmir Institute of Medical Science. Tumor types and stages were determined by two experienced pathologists. Blood samples of 150 age and sex matched cases with no signs of any malignancy were collected for controls. The mean age of both patient and control groups was 55 years.
Data on all CRC patients were obtained from personal interviews with patients and or guardians, medical records and pathology reports. The data collected included sex, age, dwelling, tumor location, Dukes Stage, lymph node status. All patients and or guardians were informed about the study and their will to participate in this study was taken on predesigned questionnaire (Available on request). The collection and use of tumor and blood samples for this study were previously approved by the appropriate Institutional Ethics Committee.
DNA extraction and genotype analysis
DNA extraction was performed using Ammonium Acetate Method. One μL of DNA was used as the template for each PCR. Genotype analysis of XRCC3 gene was carried out by PCR-RFLP using Primers (F: 5'-50-GCCTGGTGGTCATCGACTC-3; reverse, 5'-ACA G GGCTCTGGAAGGCACTGCTCAGCTC ACGCA CC-3') generating a fragment of 136 bp as described previously (Krupa et al., 2011) . Briefly, PCR was carried out in a final volume of 25 μL containing 50 ng genomic DNA template, 1X PCR buffer with 2 mM MgCl2, 0.5 μM of each primer, 50 μM dNTPs and 0.5 U DNA polymerase. For PCR amplification, the standard program was used as follows: one initial denaturation step at 94°C for 7 min, followed by 35 denaturation cycles of 1min at 94°C, 1min of annealing at 57°C, and 1 min of extension at 72°C, followed by a final elongation cycle at 72°C for 7 min.
PCR product of 136 bp was digested by 10 U NcoI at 37oC. The homozygous Thr/Thr genotype produced 39 and 97 bp fragments, heterozygous genotype displayed three fragments: 136, 97 and 39 bp and the homozygous Met/Met genotype produced one 136 bp fragment ( Figure  1 ). Restriction fragments were analysed on 3% agarose gels stained with ethidium bromide.
Statistical Analysis
Statistical analysis was performed by using SPSS Software (IBM). Observed frequencies of genotypes in cancer patients were compared to controls using chi-square or Fisher exact tests when expected frequencies were small. The chi-square test was used to verify whether genotype distributions were in Hardy-Weinberg equilibrium. Odds ratio was used to determine association of presence of mutations with various Clinico-epidemiological characteristics. Statistical significance was considered when p≤0.05.
Results
A total of 120 cases and 150 control subjects were included in this study with prior consent. All of the cases presented constipation and bleeding per rectum as their chief complaint. Furthermore, out of 120 confirmed cases of CRC, 70 were males and 50 cases were females (M/F ratio=1.4), 62 were rural and 58 were urban, 52 cases had carcinoma in colon and 68 in rectum and 63 were smokers and 57 non-smokers (Table 1 ). The mean age of patients having confirmed CRC was 55 years. Among control subjects, 84 consisted of males and 66 females (M/F ratio=1.27). No significant gender-or age-related differences were observed between the groups (p>0.05).
Among the CRC cases, we found the frequency of the XRCC3 genotype to be 60.0 per cent (72/120) for Thr/Thr, 28.33 per cent (34/120) for Thr/Met and 11.66 per cent (14/120) for Met/Met, while the frequency in the general control population was 78.6 per cent (118/150) for Thr/Thr, 14.66 per cent (22/150) for Thr/ Met and 6.66 per cent (10/150) for Met/Met. The overall association between the XRCC3 polymorphism and the CRC cases was found to be significant (p<0.05) ( Table  2) . Overall both the heterozygous genotype (Thr/Met) as well as homozygous variant genotype (Met/Met) were associated with the elevated risk for CRC [OR=2.53 (95% CI=1.37-4.66); OR=2.29(95% CI=0.96-5.4)] respectively. Also, independent analysis for the Thr/Met and Met/Met genotypes revealed a significant association with the risk of CRC (p<0.05). The overall hazard ratio of the XRCC3 Met allele in CRC was 2.29. (95% CI=0.96-5.4).
The correlation of XRCC3 polymorphic status with the clinico-pathological characteristics was also carefully analyzed. We found a significant association of variant allele of XRCC3 gene with smoking status (p value=0.05) ( Table 3) .
Discussion
In this study, we have examined whether polymorphism in DNA repair gene XRCC3, involved in the double-strand break (DSBR) DNA repair pathways, is implicated in modulating the risk of development of CRC in Kashmiri population in continuation of our previous study on XRCC1 gene polymorphism (Nissar et al., 2013) .
Since the XRCC3 protein is one of five identified paralogs of the RAD51 protein in humans and functions through complex interactions with other proteins to repair DSB and maintain genome integrity in multiple phases of HR. Double strand DNA breaks are the most dangerous DNA damage occurring either directly in cells as the result of endogenous and exogenous insults or as a result of a conversion of single strand breaks (KowalskaLoth et al., 1998) and can result in amplification or loss of genetic material which can further lead to neoplastic transformation by activation of oncogenes, inactivation of suppressor genes or loss of heterozygosity. It can be result of decrease of HRR fidelity or switch of repair over less correct process of non-homologous end joining (NHEJ).
During HRR, the XRCC3 along with Xrcc2 interacts with Rad51 and likely contributes to maintain chromosome stability. The HR pathway uses a second intact copy of a homologous chromosome as a template to copy the information lost at the DSB site, resulting in a highfidelity process and preventing chromosomal aberrations (Christmann et al., 2003) . XRCC3 deficient hamster cells showed a high frequency of multiple centrosomes and abnormal spindle formation. Also cell deficient with XRCC3 gene product are defective in HR and demonstrate genomic instability (Takata et al., 2001; Griffin, 2002; Deans et al., 2003; Thacker, 2005) suggesting its importance in repair mechanism. Thus polymorphisms of this gene may result in a reduced DNA repair capacity.
Our results show the frequency of the XRCC3 genotype to be 60.0 per cent (72/120) for Thr/Thr, 28.33 per cent (34/120) for Thr/Met and 11.66 per cent (14/120) for Met/Met, while the frequency in the general control population was 78.6 per cent (118/150) for Thr/Thr,, 14.66 per cent (22/150) for Thr/Met and 6.66 per cent (10/150) for Met/Met. The overall association between the XRCC3 polymorphism and the CRC cases was found to be significant (p<0.05) ( Table 2) . Overall both the heterozygous genotype (Thr/Met) as well as homozygous variant genotype (Met/Met) were modestly associated with the elevated risk for CRC ) respectively]. Also, individual analysis for the Thr/Met and Met/Met genotypes revealed a significant association with the risk of CRC (p<0.05). The overall hazard ratio of the XRCC3 Met allele in CRC was 2.29. (95% CI=0.96-5.4). Our findings are in concordance with those reported by Mort et al. (2003) , Krupa et al. (2011) and Importa et al. (2008) and contradictory to those reported by many authors (Tranah et al., 2004; Stern et al., 2005; Yeh et al., 2005; Skjelbred et al., 2006) which show negative association. Also, it has been suggested that variant genotypes of XRCC3 have decreased repair capacity and thus individuals with this genotypes do not repair double strand DNA breaks efficiently by HRR and are susceptible to risk of CRC (Krupa et al., 2011) . XRCC3 plays a key role in maintaining the genome integrity and substitution of Thr to Met in codon 241 is the most frequent polymorphism in XRCC3 that may affect the biological implications of the enzyme's function and thus alter DNA repair capacity as well (Matullo et al., 2001; Jin et al., 2005) .
Further we also found association of polymorphism with the smoking status which is in agreement with study of Matullo et al. 2001 study who has associated the 241Met polymorphism with 32P-DNA adduct levels, indicating a possible role of the XRCC3 gene in the repair of bulky DNA adducts. Thus, variations in DNA repair capacity caused by polymorphisms of DNA repair genes may modulate the genotoxic effect of tobacco smoking.
Our results suggest that genetic polymorphism of the XRCC3 gene may be associated with an individual's susceptibility to colorectal cancer. However, we acknowledge the relatively limited sample size as a limitation of this study as there are number of variables that may affect the outcome of the genotype vis a vis polymorphism of this gene in interaction with the environment.
In conclusion, this study displays a significantly elevated risk for colorectal cancer in individuals with XRCC3 Thr/Met and Met/Met genotypes, suggesting DSBR DNA repair pathway is modulating the risk of developing CRC in Kashmiri population with almost two and half times than Thr/Thr genotype.
